Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 38,789 | 18,581 | 10,033 | 25,445 | 18,533 |
| Depreciation Amortization | 16,569 | 12,413 | 7,892 | 40,299 | 28,567 |
| Income taxes - deferred | 5,189 | 2,539 | 2,379 | 16,802 | 4,612 |
| Accounts receivable | 29,148 | 31,789 | -24,309 | 32,708 | 2,119 |
| Accounts payable and accrued liabilities | -14,972 | -28,837 | N/A | 1,649 | -67,938 |
| Other Working Capital | 25,945 | 21,308 | -8,845 | -37,907 | -78,180 |
| Other Operating Activity | -14,450 | -2,500 | 20,627 | -47,246 | 67,387 |
| Operating Cash Flow | $86,218 | $55,293 | $7,777 | $31,750 | $-24,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 189,867 | 73,716 | -31,860 | -105,709 | -118,922 |
| PPE Investments | -48,229 | -13,800 | -6,793 | -17,577 | -11,186 |
| Purchase Of Investment | N/A | N/A | N/A | -1,976 | N/A |
| Purchase Sale Intangibles | -99 | -50 | -51 | -294 | -122 |
| Other Investing Activity | -99 | -50 | -51 | -294 | -2,122 |
| Investing Cash Flow | $141,539 | $59,866 | $-38,704 | $-125,556 | $-132,230 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 157 | -643 | 597 | -2,833 | -2,031 |
| Beginning Cash Position | 154,495 | 154,495 | 154,495 | 251,134 | 251,134 |
| End Cash Position | 382,409 | 269,011 | 124,165 | 154,495 | 91,973 |
| Net Cash Flow | $227,914 | $114,516 | $-30,330 | $-96,639 | $-159,161 |
| Free Cash Flow | |||||
| Operating Cash Flow | 86,218 | 55,293 | 7,777 | 31,750 | -24,900 |
| Capital Expenditure | -48,229 | -13,800 | -6,793 | -17,577 | -11,186 |
| Free Cash Flow | 37,989 | 41,493 | 984 | 14,173 | -36,086 |